Moreover, miR-497 is able to function as a tumor-suppressor miRNA in NSCLC by targeting the vascular endothelial growth factor A (VEGF-A) [107], cyclin E1 [108] and the Yes-associated protein 1 (YAP1) [109,110]. Here, VEGFA is linked to neoplasm.